Dec 01, · General interest in bitcoin looks to have risen alongside the top cryptocurrency’s rally to a new peak price. As of last week, Google Trends, a barometer for gauging general or retail interest. Sep 06, · Bitcoin and cryptocurrency prices are well known to be closely tied to media and general public interest –- though that could be changing. The bitcoin price has been climbing so far this year, Author: Billy Bambrough. Explore search interest for bitcoin by time, location and popularity on Google Trends.
Bitcoin price google trendsGoogle Searches for ‘Bitcoin Price’ Hit Month High
It caused a massive interest on Google Search and on Google Trends. This time around, barely anyone outside of the crypto or the finance world is talking about Bitcoin at this point. The public that once was enamored by the lure of untold wealth and a new, mysterious technology created by a pseudonymous mastermind have all but forgotten about crypto.
There was no denying Bitcoin was in a bubble. People hearing about Bitcoin during water cooler talk or reading stories in the newspaper about year old millionaires who bought the asset early on with allowance money had their curiosity — and greed — piqued. It caused them to flock to Google first to inquire what the digital asset even was, before searching for how to buy it, and finding themselves on the likes of Coinbase , driving up the price further. This is clearly depicted on the five-year Google Trends chart for Bitcoin.
Compared to then, the current price action is causing barely a blip on the chart. Most other longer timeframes show a decline in Google Trends , until what looks like a bull flag appears on the end of the 7-day. Might we see a similar spike on Google Trends soon enough?
I'm Tony Spilotro. Behind the pseudonym, I'm a digital media executive and global remote work leader with a decade of content experience and excellent. Here, I explore my newfound passions pertaining to privacy, finance, economics, politics, cryptography, property rights, and other libertarian-esque views.
I am a Bitcoin evangelist, maximalist, and educator whenever I can be, helping to spread its message of freedom from government control, monetary policy mismanagement, and passing the buck - literally — to future generations. My journey from a curious retail crypto investor to a serious Bitcoin advocate, trader, and technical analyst is an unusual one, but life-changing nonetheless and has become less about money and more about a long-overdue revolution.
While a firm believer in the laws governing math and science, I am profoundly fascinated by the impact of astrology and astronomy including moon and solar cycles and planetary alignment and their ability to influence and potentially predict markets. It hasn't yet clicked for me as to how to put anything to use, but I consider it my current rabbit hole I can't yet dig out of.
My perspective of growing up alongside the internet, the dot com era, the Great Recession, and roots in video games collecting coins and rare items caused Bitcoin to immediately make sense to me.
Through all of these lenses, I seek to produce content that is educational and entertaining, and I thank you sincerely for taking the time to read what I have to say. Please follow me on Twitter and feel free to drop me a line if you would like to work together.
Here at NewsBTC, we are dedicated to enlightening everyone about bitcoin and other cryptocurrencies. We cover BTC news related to bitcoin exchanges, bitcoin mining and price forecasts for various cryptocurrencies. All Rights Reserved. A new year, a new addition to the stock portfolio — what can make more sense than that? The right time to buy, of course, is when stocks are priced at the bottom. But the markets are up. With a market environment like that, finding stocks that are caught in the doldrums is harder than it looks.
That's where the Wall Street pros can lend a hand. Not to mention each has earned a Moderate or Strong Buy consensus rating. Esperion ESPR We will start with Esperion, a company that specializes in therapies for the treatment of elevated low-density lipoprotein cholesterol levels — a major factor contributing to heart disease.
Bempedoic acid remains in clinical trials of its efficacy in risk reduction for cardiovascular disease. The trial, called CLEAR Outcomes, is a large-scale, long-term study, tracking more than 14, patients with top-line data expected in the second half of The study covers 1, locations in 32 countries around the world.
Esperion shares peaked last February, after the FDA approvals, but since then, the stock has declined. The offering gives the company a boost in available capital for further work on its development pipeline and its marketing efforts for bempedoic acid.
We believe this financing should help put to rest concerns regarding Esperion's balance sheet. This growth trajectory suggests potential for a rapid acceleration when conditions improve," Messer wrote. Intercept has a research pipeline based on FXR, a regulator of bile acid pathways in the hepatic system. The effect on the stock is still felt, and ICPT remains at its week low point. In reaction, in December of , Intercept announced major changes in top-level management, as CEO and President Mark Pruzanski announced he's stepping down effective January 1 of this year.
Pruzanski's dedication to transform the liver space is still strong, and that he will continue to guide ICPT's progress as an advisor and Board member. By November, however, even though remdesivir had been approved, the World Health Organization WHO was recommending against its use, and the COVID vaccines now on the market have made remdesivir irrelevant to the pandemic. The company has been working, in conjunction with Galapagos GLPG , on development of filgotinib as a treatment for rheumatoid arthritis.
Looking at the consensus breakdown, opinions from other analysts are more spread out. The Alibaba Trades: On Tuesday morning, Benzinga Pro subscribers received dozens of option alerts related to unusually large Alibaba option trades. Why It's Important: Even traders who stick exclusively to stocks often monitor option market activity closely for unusually large trades.
Given the relative complexity of the options market, large options traders are typically considered to be more sophisticated than the average stock trader. Many of these large options traders are wealthy individuals or institutions who may have unique information or theses related to the underlying stock.
Unfortunately, stock traders often use the options market to hedge against their larger stock positions, and there's no surefire way to determine if an options trade is a standalone position or a hedge. In this case, given the relatively large sizes of Tuesday's biggest Alibaba option trades, they could certainly be institutional hedging. China has cracked down on Alibaba and its affiliate Ant Financial after Ma made critical comments about Chinese government regulators back in October.
Ma hasn't made a public appearance in months, leading some to speculate that the Chinese Communist Party had Ma imprisoned or worse following his comments. While Alibaba is far from out of the woods when it comes to the regulatory crackdown, CNBC reported Ma has simply been lying low and avoiding the public eye since his controversial comments.
Benzinga does not provide investment advice. All rights reserved. An analyst at Cantor Fitzgerald sees the grower as the best-positioned Canadian firm he covers to benefit from U. Pointing to contingent stakes in U. Furthermore, it is important to note that the company has no entanglement with the environmental liabilities that burden its legacy competition. Put it all together and we believe Tesla's business model can unlock recurring mobility services revenue faster and more profitably than the competition," the analyst said.
Dow Futures 30, Nasdaq Futures 12, Russell Futures 2, Crude Oil